JP2007517016A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007517016A5 JP2007517016A5 JP2006546397A JP2006546397A JP2007517016A5 JP 2007517016 A5 JP2007517016 A5 JP 2007517016A5 JP 2006546397 A JP2006546397 A JP 2006546397A JP 2006546397 A JP2006546397 A JP 2006546397A JP 2007517016 A5 JP2007517016 A5 JP 2007517016A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- solid composition
- composition according
- particles
- poloxamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 claims 26
- 229940079593 drug Drugs 0.000 claims 25
- 239000008247 solid mixture Substances 0.000 claims 15
- 239000002245 particle Substances 0.000 claims 13
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 6
- 229960000502 poloxamer Drugs 0.000 claims 6
- 229920001983 poloxamer Polymers 0.000 claims 6
- 230000009477 glass transition Effects 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims 1
- 229940081735 acetylcellulose Drugs 0.000 claims 1
- 229920002301 cellulose acetate Polymers 0.000 claims 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims 1
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 125000005591 trimellitate group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53383603P | 2003-12-31 | 2003-12-31 | |
| PCT/IB2004/004287 WO2005065657A2 (en) | 2003-12-31 | 2004-12-20 | Solid compositions of low-solubility drugs and poloxamers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007517016A JP2007517016A (ja) | 2007-06-28 |
| JP2007517016A5 true JP2007517016A5 (https=) | 2008-02-14 |
Family
ID=34748969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006546397A Abandoned JP2007517016A (ja) | 2003-12-31 | 2004-12-20 | 低溶解性薬剤及びポロキサマーの固体組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8974823B2 (https=) |
| EP (1) | EP1701704A2 (https=) |
| JP (1) | JP2007517016A (https=) |
| BR (1) | BRPI0418330A (https=) |
| CA (1) | CA2548376A1 (https=) |
| WO (1) | WO2005065657A2 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005047561A1 (de) * | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
| WO2008119659A2 (en) * | 2007-03-29 | 2008-10-09 | F. Hoffmann-La Roche Ag | Pharmaceutical composition and process |
| DK2200588T3 (da) * | 2007-09-25 | 2019-07-01 | Solubest Ltd | Sammensætninger, som omfatter lipofile aktive forbindelser, og fremgangsmåde til fremstilling deraf |
| WO2011106702A2 (en) | 2010-02-25 | 2011-09-01 | The Johns Hopkins University | Sustained delivery of therapeutic agents to an eye compartment |
| PH12013500082B1 (en) * | 2010-07-12 | 2019-06-28 | Salix Pharmaceuticals Ltd | Formulations of rifaximin and uses thereof |
| US20170087134A1 (en) * | 2010-07-12 | 2017-03-30 | Salix Pharmaceuticals, Ltd | Formulations of rifaximin and uses thereof |
| US10307372B2 (en) | 2010-09-10 | 2019-06-04 | The Johns Hopkins University | Rapid diffusion of large polymeric nanoparticles in the mammalian brain |
| EP2455068A1 (en) * | 2010-11-09 | 2012-05-23 | F. Hoffmann-La Roche AG | Pharmaceutical composition for treating HCV infections |
| US9364476B2 (en) * | 2011-10-28 | 2016-06-14 | Celgene Avilomics Research, Inc. | Methods of treating a Bruton's Tyrosine Kinase disease or disorder |
| US8962577B2 (en) | 2012-03-16 | 2015-02-24 | The Johns Hopkins University | Controlled release formulations for the delivery of HIF-1 inhibitors |
| JP6138904B2 (ja) | 2012-03-16 | 2017-05-31 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 活性剤の送達のための非線状マルチブロックコポリマー薬物コンジュゲート |
| CN111700879A (zh) * | 2012-05-03 | 2020-09-25 | 卡拉制药公司 | 显示提高的粘膜转移的药物纳米粒子 |
| US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
| JP6360039B2 (ja) | 2012-05-03 | 2018-07-18 | カラ ファーマシューティカルズ インコーポレイテッド | 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法 |
| ES3055223T3 (en) | 2012-05-03 | 2026-02-10 | Alcon Inc | Pharmaceutical nanoparticles showing improved mucosal transport |
| US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
| AU2013256008B2 (en) | 2012-05-04 | 2016-02-25 | The Johns Hopkins University | Lipid-based drug carriers for rapid penetration through mucus linings |
| US10568975B2 (en) | 2013-02-05 | 2020-02-25 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
| MX2015009952A (es) | 2013-02-08 | 2015-10-05 | Celgene Avilomics Res Inc | Inhibidores de cinasas reguladas por señales extracelulares (erk) y sus usos. |
| JP5946798B2 (ja) * | 2013-06-18 | 2016-07-06 | 住友ゴム工業株式会社 | タイヤ用ゴム組成物、及び空気入りタイヤ |
| JP5934677B2 (ja) * | 2013-06-18 | 2016-06-15 | 住友ゴム工業株式会社 | タイヤ用ゴム組成物、及び空気入りタイヤ |
| US9492471B2 (en) | 2013-08-27 | 2016-11-15 | Celgene Avilomics Research, Inc. | Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase |
| JP6010060B2 (ja) * | 2014-02-21 | 2016-10-19 | 住友ゴム工業株式会社 | タイヤ用ゴム組成物、及び空気入りタイヤ |
| EP3179858B1 (en) | 2014-08-13 | 2019-05-15 | Celgene Car Llc | Forms and compositions of an erk inhibitor |
| RU2639819C2 (ru) * | 2014-12-30 | 2017-12-22 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Композиция, ингибирующая теломеразу |
| KR20240126072A (ko) | 2015-01-27 | 2024-08-20 | 더 존스 홉킨스 유니버시티 | 점막표면에서 활성제의 향상된 수송을 위한 저장성 하이드로겔 제제 |
| JP7027412B2 (ja) | 2016-09-30 | 2022-03-01 | サリックス ファーマスーティカルズ，インコーポレーテッド | リファキシミンの固体分散体の形態 |
| US12496279B2 (en) | 2019-04-11 | 2025-12-16 | The Johns Hopkins University | Nanoparticles for drug delivery to brain |
| JP7825575B2 (ja) | 2020-06-26 | 2026-03-06 | バウシュ ヘルス アイルランド リミテッド | 標的化放出リファキシミン組成物 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE80467B1 (en) | 1995-07-03 | 1998-07-29 | Elan Corp Plc | Controlled release formulations for poorly soluble drugs |
| DE69811233T2 (de) | 1997-10-27 | 2003-11-20 | Merck Patent Gmbh | Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes |
| EP1103258A1 (en) | 1998-07-22 | 2001-05-30 | Yamanouchi Pharmaceutical Co. Ltd. | Solid preparation containing sparingly soluble nsaids |
| US6368622B2 (en) | 1999-01-29 | 2002-04-09 | Abbott Laboratories | Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| US6264981B1 (en) | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
| EP1175205B1 (en) | 1999-11-12 | 2006-06-14 | Abbott Laboratories | Solid dispersion comprising ritonavir, fenofibrate or griseofulvin |
| CA2390092C (en) | 1999-11-12 | 2009-07-14 | Abbott Laboratories | Solid dispersion pharmaceutical formulations |
| HUP0201450A3 (en) | 1999-12-08 | 2003-02-28 | Pharmacia Corp Chicago | Solid-state form of celecoxib having enhanced bioavailability, pharmaceutical compositions containing it and their preparation |
| CN1402629A (zh) | 1999-12-23 | 2003-03-12 | 辉瑞产品公司 | 提供提高的药物浓度的药物组合物 |
| JP2003521493A (ja) | 2000-01-28 | 2003-07-15 | スミスクライン・ビーチャム・コーポレイション | 電気紡糸された医薬組成物 |
| PE20011184A1 (es) * | 2000-03-16 | 2001-11-15 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la glucogeno-fosforilasa |
| US20010053791A1 (en) * | 2000-03-16 | 2001-12-20 | Babcock Walter C. | Glycogen phosphorylase inhibitor |
| US20010036959A1 (en) | 2000-04-03 | 2001-11-01 | Gabel Rolf Dieter | Carvedilol-hydrophilic solutions |
| EP1276465B1 (en) | 2000-04-20 | 2014-03-12 | Jagotec AG | Improved water-insoluble drug particle process |
| US6316029B1 (en) | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
| GB0015239D0 (en) | 2000-06-21 | 2000-08-16 | Biochemie Gmbh | Organic compounds |
| DE10038571A1 (de) | 2000-08-03 | 2002-02-14 | Knoll Ag | Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen |
| KR20020014570A (ko) | 2000-08-18 | 2002-02-25 | 김충섭 | 고체분산화시킨 무정형 이프리플라본의 제조방법 |
| CN1255185C (zh) * | 2001-05-03 | 2006-05-10 | 弗·哈夫曼-拉罗切有限公司 | 无定形甲磺酸奈非那韦的药物剂型 |
| US20030054042A1 (en) * | 2001-09-14 | 2003-03-20 | Elaine Liversidge | Stabilization of chemical compounds using nanoparticulate formulations |
| PL372247A1 (en) * | 2002-02-01 | 2005-07-11 | Pfizer Products Inc. | Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| EP1480619B1 (en) * | 2002-03-07 | 2013-08-07 | Biocompatibles UK Limited | Drug carriers comprising amphiphilic block copolymers |
-
2004
- 2004-12-20 JP JP2006546397A patent/JP2007517016A/ja not_active Abandoned
- 2004-12-20 EP EP04806454A patent/EP1701704A2/en not_active Withdrawn
- 2004-12-20 BR BRPI0418330-4A patent/BRPI0418330A/pt not_active IP Right Cessation
- 2004-12-20 WO PCT/IB2004/004287 patent/WO2005065657A2/en not_active Ceased
- 2004-12-20 CA CA002548376A patent/CA2548376A1/en not_active Abandoned
- 2004-12-20 US US10/596,876 patent/US8974823B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007517016A5 (https=) | ||
| CN104857515B (zh) | 一种控释给药的药芯组合物以及包含该药芯组合物的渗透泵制剂 | |
| MXPA02001243A (es) | Medios para crear una masa que tiene integridad estructural. | |
| JP2009502487A5 (https=) | ||
| CN107854435A (zh) | 葡萄糖激酶激活剂的口服制剂及其制备方法 | |
| CN1503662A (zh) | 药物制剂 | |
| JP6364406B2 (ja) | 口腔内崩壊錠 | |
| JP2017532363A5 (https=) | ||
| KR102727681B1 (ko) | 덱스란소프라졸 또는 이의 약학적으로 허용 가능한 염을 함유하는 안정한 경구투여용 약학 제제 | |
| CN103550158B (zh) | 一种大黄素固体分散体、含药丸芯和结肠靶向微丸及其用途 | |
| CN102548543B (zh) | 具有改进的溶出率和最小的副作用的缓释的西洛他唑片剂 | |
| TW201110968A (en) | A thrombin receptor antagonist and clopidogrel fixed dose tablet | |
| JP2010536837A5 (https=) | ||
| CN101773478B (zh) | 一种兽用头孢噻呋盐酸盐的肺靶向微球及制备方法 | |
| JP6156037B2 (ja) | 固形医薬製剤組成物 | |
| CN110946835A (zh) | 一种利伐沙班固体分散片及其制备方法 | |
| BR112014026040B1 (pt) | Comprimido de liberação sustentada que contém levodropropizina | |
| TW201904572A (zh) | 非布司他控釋組合物及其製備方法 | |
| CN104971052A (zh) | 含有非马沙坦钾三水合物的药物组合物及其制备方法 | |
| CN105726515A (zh) | 一种宠物用西地那非口腔膜剂及其制备方法 | |
| CN100441201C (zh) | 含积雪草水溶性有效组分的中药缓释制剂及其制备方法 | |
| CN115671070B (zh) | 枸橼酸地氯雷他定渗透泵控释片以及制备方法 | |
| CN105616370A (zh) | 一种雷诺嗪缓释片药物组合物及其制备方法 | |
| CN103191048B (zh) | 一种齐墩果酸生物黏附制剂的制备方法 | |
| CN104013582A (zh) | 一种阿司匹林peg-plga微球及其制备方法 |